Decent volume - 1.75m shares so someone is obviously positioning for a positive announcement.
Printable View
a conservative case valuation of NZ$0.64 per share – Tenon NZ$0.36 (lower end of range),
plus ArborGen existing NZ$0.33, (ie base value net of current debt) and including Rubicon net
debt of NZ$0.05 per share.
a more bullish case valuation of NZ$1.06 per share – Tenon NZ$0.47, plus ArborGen total
NZ$0.64 (net of current debt), again including an NZ$0.05 per share adjustment for Rubicon
net debt. Ex Edison
Good volumes again today.Wondering if wise men are buying or wiser men selling.
Last update says.......an announcement in respect of the outcome of its Strategic
Review process either in conjunction with, or prior to, the release of the
Company's 30 June 2016 financial results..........watching very closely, this will definately be make or break.....
I cant understand the muted sharemarket response to Rubicon. The 2009 Grant Samuel analysis, at a time of depression type new housing activity in the USA valued Rubicon at a range of $1.09 to $2.26 assuming they consent to the sale of Tenon. Now that valuation was 7 years ago. I would have thought a 24c share would potentially skyrocket in this scenario. Is it a case of under the radar??
That was then, and this is now :
Tenon is valued at between $3.01 to $3.25 - so total valuation of $195m to $211m.
RBC owns 59% of Tenon so RBC's share will be $115m to $124m or 28c to 30c per share.
With RBC shares being offered at 26c on market, market clearly is placing zero value or even negative value on AborGen - which could be the hidden gem when it finally gets sold or floated?
If TENON only sell the USA part of their operation will Tenon stay listed and at what price?
Can't do any harm to Rubicon.........Scion are in partnership with Arbogen....http://www.nzherald.co.nz/nz/news/ar...ectid=11702838